Asangani IA - Search Results

1

NRF-1, and AP-1 regulate the promoter of the human calpain small subunit 1 (CAPNS1) gene.

Asangani IA, Rasheed SA, Leupold JH, Post S, Allgayer H. Asangani IA, et al. Gene. 2008 Feb 29;410(1):197-206. doi: 10.1016/j.gene.2007.12.009. Epub 2007 Dec 23. Gene. 2008. PMID: 18234454

2

Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.

Leupold JH, Asangani I, Maurer GD, Lengyel E, Post S, Allgayer H. Leupold JH, et al. Mol Cancer Res. 2007 May;5(5):485-96. doi: 10.1158/1541-7786.MCR-06-0211. Mol Cancer Res. 2007. PMID: 17510314 Free article.

3

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.

Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. Asangani IA, et al. Oncogene. 2008 Apr 3;27(15):2128-36. doi: 10.1038/sj.onc.1210856. Epub 2007 Oct 29. Oncogene. 2008. PMID: 17968323

4

Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.

Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H. Leupold JH, et al. Oncogene. 2007 Jul 5;26(31):4550-62. doi: 10.1038/sj.onc.1210234. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297470

5

Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.

Schewe DM, Biller T, Maurer G, Asangani IA, Leupold JH, Lengyel ER, Post S, Allgayer H. Schewe DM, et al. Among authors: asangani ia. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8538-48. doi: 10.1158/1078-0432.CCR-05-0786. Clin Cancer Res. 2005. PMID: 16361535

6

Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators.

Leupold JH, Asangani IA, Mudduluru G, Allgayer H. Leupold JH, et al. Among authors: asangani ia. Biosci Rep. 2012 Jun;32(3):281-97. doi: 10.1042/BSR20110045. Biosci Rep. 2012. PMID: 22111549 Free article.

7

Cetuximab attenuates metastasis and u-PAR expression in non-small cell lung cancer: u-PAR and E-cadherin are novel biomarkers of cetuximab sensitivity.

Nikolova DA, Asangani IA, Nelson LD, Hughes DP, Siwak DR, Mills GB, Harms A, Buchholz E, Pilz LR, Manegold C, Allgayer H. Nikolova DA, et al. Among authors: asangani ia. Cancer Res. 2009 Mar 15;69(6):2461-70. doi: 10.1158/0008-5472.CAN-08-3236. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276367

8

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.

Rasheed SA, Efferth T, Asangani IA, Allgayer H. Rasheed SA, et al. Among authors: asangani ia. Int J Cancer. 2010 Sep 1;127(6):1475-85. doi: 10.1002/ijc.25315. Int J Cancer. 2010. PMID: 20232396

9

Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.

Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD, Allgayer H. Mudduluru G, et al. Among authors: asangani ia. Biosci Rep. 2011 Jun;31(3):185-97. doi: 10.1042/BSR20100065. Biosci Rep. 2011. PMID: 20815812

10

Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression.

Wang H, Yan C, Asangani I, Allgayer H, Boyd DD. Wang H, et al. Oncogene. 2007 Mar 29;26(14):2058-70. doi: 10.1038/sj.onc.1210003. Epub 2006 Sep 25. Oncogene. 2007. PMID: 17001307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters